Atabak Mokari Insider Profile
4 Followers
Atabak Mokari, CFO and VP Corp Development at Iridex, holds 81.79K shares in Iridex (Ticker: IRIX), holds ― shares in Bellicum Pharmaceuticals (Ticker: BLCM), holds 16.13K shares in Corcept Therapeutics (Ticker: CORT).
Atabak Mokari has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Atabak Mokari holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Atabak Mokari
Atabak Mokari's Trading History
Iridex
Dec 13, 2018
CFO and VP Corp Development
Uninformative Sell
738.00
$91.60K
Bellicum Pharmaceuticals
―
―
―
―
Corcept Therapeutics
Jun 17, 2026
CFO
Uninformative Buy
770.40K
$1.50M
List of latest transactions for each holding click on a transaction to see Atabak Mokari's performance on stock
You May Also Like
Atabak Mokari insider profile FAQ
What is the percentage of profitable transactions made by Atabak Mokari?
The percentage of profitable transactions made by Atabak Mokari is ―.
What is the average return per transaction made by Atabak Mokari?
The average return per transaction made by Atabak Mokari is ―.
What stocks does Atabak Mokari hold?
Atabak Mokari holds: IRIX, BLCM, CORT stocks.
What was Atabak Mokari’s latest transaction?
Atabak Mokari latest transaction was an Uninformative Sell of $738.00.
What was Atabak Mokari's most profitable transaction?
Atabak Mokari’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Atabak Mokari's role in Iridex?
Atabak Mokari's role in Iridex is CFO and VP Corp Development.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.